Bolstered by government support, a wealth of investment and an eager graduate workforce, the country’s biotechnology industry is booming.
India’s pharmaceutical sector has long been dominated by major generics manufacturers. Over the last decade, though, the world’s second-most-populous country is beginning to develop new medical technology, in part to help fix its unique healthcare problems. What went right, and what is there still to do?
A conversation with Krishnarao Appasani, vice-chair and chief executive officer, Science City of Andhra Pradesh
A conversation with Vinod Bhat, vice chancellor, Manipal Academy of Higher Education